Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-783,800
Closed -$35.6M 106
2017
Q2
$35.6M Buy
783,800
+59,800
+8% +$2.64M 1.12% 34
2017
Q1
$30.8M Buy
724,000
+20,600
+3% +$840K 1.02% 30
2016
Q4
$28.2M Sell
703,400
-106,900
-13% -$4.13M 1.01% 32
2016
Q3
$31.5M Sell
810,300
-25,300
-3% -$955K 1.16% 10
2016
Q2
$28.9M Buy
835,600
+270,800
+48% +$9.38M 1.21% 25
2016
Q1
$19.5M Buy
564,800
+136,800
+32% +$4.77M 0.95% 62
2015
Q4
$16.6M Buy
+428,000
New +$16.7M 1.09% 58

Other funds holding HOLX

Ardevora Asset Management's HOLX Position: Q3 2017 in Review

Ardevora Asset Management sold out of Hologic (HOLX) in Q3 2017, closing a stake of 783,800 shares — an estimated $35.6M sold.

Ardevora Asset Management first reported a position in HOLX in Q4 2015 and held it in 7 quarters. The position peaked at $35.6M in Q2 2017. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Ardevora Asset Management reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Ardevora Asset Management sold 783,800 Hologic shares in Q3 2017, an estimated $35.6M.
  • Ardevora Asset Management first reported a position in Hologic in Q4 2015 and held it in 7 quarters.
  • Ardevora Asset Management's Hologic position peaked at $35.6M in Q2 2017.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Ardevora Asset Management's 13F filing for Q3 2017, filed 6 Nov 2017.